Cannabinoids for Cancer
Patent filings for treating cancer with cannabinoids has been on a steady increase over the past few years. Already in January 2022, two patents have been published for treating cancer with cannabinoids. Patent Forecast® highlighted GW Pharmaceuticals’ jump into cannabis treatments for cancer, especially after its acquisition by Jazz Pharmaceuticals. GW Pharmaceuticals has become the top assignee in the cannabis for cancer space. Now others are following suit and racing to file.
Dana-Farber Cancer, a comprehensive cancer treatment and research institution in Massachusetts, had a patent publish in January 2022 for immunotherapy compositions containing cannabinoids. We will be following DFC’s involvement in the cannabis space, so stay tuned!
Studies surrounding how effective cannabis is as a cancer treatment are still in progress and developing. Some studies have suggested that certain cannabinoids like THCV could be useful in reducing cancer cell division. Others have focused on treating cachexia and nausea induced from chemotherapy, keying in on cannabis’ stimulation properties. There are currently 4 active US clinical trials to study cannabinoid affects on cancer and treating symptoms of cancer and cancer treatment with cannabinoids.
Join the Cannabis Patent Forecast® to explore over 100 patent assets covering treatment of cancer with cannabinoids early on in the market!
Related Posts
May 20, 2021
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
April 15, 2021
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
April 8, 2021
Driving While High? Cannabis Sobriety Testing Heats Up
What’s the future of cannabis innovation? We see things before they happen using our Patent Forecast®. One of those is the development of…